Ionis Pharmaceuticals Inc. (IONS) can’t be written off after posting last 3-months Average volume of 1.17M

Ionis Pharmaceuticals Inc. (IONS) is priced at $58.59 after the most recent trading session. At the very opening of the session, the stock price was $55.77 and reached a high price of $58.84, prior to closing the session it reached the value of $55.34. The stock touched a low price of $55.39.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on December 17, 2020, Stanley T. Crooke, Ph.D., M.D, to retire from Ionis to focus on his scientific interests and n-Lorem Foundation. Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that its founder and executive chairman Stanley T. Crooke, M.D., Ph.D., will retire from Ionis and its board of directors effective June 2021. Dr. Crooke is stepping down so that he may focus on his scientific interests and the nonprofit organization he founded, the n-Lorem Foundation. Dr. Crooke will continue to serve as a scientific advisor to Ionis including providing advice regarding Ionis’ research and development programs and guiding the core antisense research group he founded at Ionis. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Ionis Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $64.34 on 01/09/20, with the lowest value was $39.32 for the same time period, recorded on 03/23/20.

Ionis Pharmaceuticals Inc. (IONS) full year performance was -5.67%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ionis Pharmaceuticals Inc. shares are logging -8.94% during the 52-week period from high price, and 49.01% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $39.32 and $64.34.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2147873 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Ionis Pharmaceuticals Inc. (IONS) recorded performance in the market was -3.01%, having the revenues showcasing 18.77% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.72B, as it employees total of 817 workers.

Analysts verdict on Ionis Pharmaceuticals Inc. (IONS)

During the last month, 9 analysts gave the Ionis Pharmaceuticals Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 4 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 50.61, with a change in the price was noted +1.03. In a similar fashion, Ionis Pharmaceuticals Inc. posted a movement of +1.79% for the period of last 100 days, recording 1,024,411 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IONS is recording 0.59 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.59.

Ionis Pharmaceuticals Inc. (IONS): Technical Analysis

Raw Stochastic average of Ionis Pharmaceuticals Inc. in the period of last 50 days is set at 98.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 98.16%. In the last 20 days, the company’s Stochastic %K was 97.47% and its Stochastic %D was recorded 91.29%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Let’s take a glance in the erstwhile performances of Ionis Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -3.01%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -0.86%, alongside a downfall of -5.67% for the period of the last 12 months. The shares increased approximately by 13.80% in the 7-day charts and went down by 19.23% in the period of the last 30 days. Common stock shares were driven by 18.77% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here